-
Valeant's 10k Finally Released
Friday, April 29, 2016 - 8:39am | 248Read More...Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) were trading lower by nearly 2 percent early morning after the company released its delayed 10-k filing which includes its first quarter results. Valeant reported it lost $1.12 per share in the first quarter on revenue of $2.76 billion....
-
Valeant Says Delayed 10-K Resulted In Several Notices Of Defaults
Monday, April 25, 2016 - 10:29am | 184Read More...Valeant Pharmaceuticals International, Inc. (NYSE: VRX) announced on Friday it has received several notices of defaults from trustees as a the result of its delayed 10-K filing. Valeant continued that the notices of default governing its 5.375 percent Senior Notes due 2020; 6.375 percent Senior...
-
Valeant Withdraws Prior Guidance, Announces CEO Mike Pearson Will Return To Work Immediately Following Pneumonia Scare
Monday, February 29, 2016 - 8:35am | 250Read More...Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) plunged more than 8 percent early Monday morning after the company issued a business update over the weekend. Valeant confirmed that Michael Pearson will resume his role as CEO, effective immediately. The executive was hospitalized...
